BioInvent International

22.40 SEK

+3.94%

Less than 1K followers

BINV

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioInvent International

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Revenue21.444.722.1198.13.33.0226.513.4
EBITDA-121.0-451.8-117.734.1-128.8-119.5-331.8-116.9
EBIT-125.9-471.1-122.834.1-133.6-129.4-351.7-121.8
EBIT-%-589.0 %-1,054.1 %-556.6 %17.2 %-4,023.1 %-4,285.1 %-155.3 %-907.2 %
Profit before taxes-116.8-429.2-116.638.9-129.1-125.6-332.5-119.2
Net income-116.9-429.4-116.638.8-129.2-125.8-332.9-119.2